Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-046329
Filing Date
2022-04-15
Accepted
2022-04-15 11:16:47
Documents
4
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2211747d1_def14a.htm DEF 14A 381975
2 GRAPHIC img001.jpg GRAPHIC 12221
3 GRAPHIC img004.jpg GRAPHIC 206253
4 GRAPHIC img005.jpg GRAPHIC 77867
  Complete submission text file 0001104659-22-046329.txt   784405
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20713 | Film No.: 22829339
SIC: 2836 Biological Products, (No Diagnostic Substances)